Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bellicum snags $20M for mid-stage cancer vaccine program
Bellicum snags $20M for mid-stage cancer vaccine program
Bellicum snags $20M for mid-stage cancer vaccine program
Submitted by
admin
on March 8, 2012 - 3:33pm
Source:
Fierce Biotech
News Tags:
BPX-101
prostate cancer
Bellicum
Headline:
Bellicum snags $20M for mid-stage cancer vaccine program
Do Not Allow Advertisers to Use My Personal information
